|
|
|
|
| Clinical Innovation Meets Manufacturing Excellence | E-Book | Altasciences | Discover how our ClinDMO model transforms early drug development with on-demand manufacturing, adaptive formulation, and real-time decision-making to accelerate timelines and optimize API use. |
|
|
|
|
By Louis Garguilo, chief editor, Outsourced Pharma | Just over a year ago, AstraZeneca went all in on creating a cell-therapy franchise; Samir Panjwani joined as a supplier-relationship manager. “I’ve been a builder throughout my career,” he says. The question he’s always kept in mind: Why are we in this industry? He discusses his new role, and his “bilateral experiences” supporting manufacturing outsourcing supply chains. | |
|
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
| Science To Success: CMC Strategies That Drive Market Readiness | Article | By Neha Shah, Ph.D., and Kiran Pedada, Ph.D., Bend Bioscience | Learn how a scientifically grounded framework for early-phase CMC development, integrating QbD and risk management, de-risks drug development and accelerates the journey from molecule to market. |
|
|
| The Future Of Sustainable Amorphous Dispersion Development | Article | By Elizabeth Hickman, AustinPx | Sustainable amorphous dispersion cuts cost, risk, and timelines by removing solvent waste, simplifying manufacturing, strengthening supply chains, and scaling efficiently to commercialization. |
|
|
|
|
|
|
|
|
OUTSOURCED PHARMA CAPABILITIES UPDATE |
|
|
|
CDMOs in biologics, cell and gene, and small molecule share their capabilities and available capabilities. See for yourself why this virtual event has become a wildly popular resource to identify options for your development and manufacturing needs. |
|
|
| Connect With Outsourced Pharma: |
|
|
|
